Cooper, A. G., Oyagawa, C. R. M., Manning, J. J., Singh, S., Hook, S., Grimsey, N. L., . . . Vernall, A. J. (2018). Development of selective, fluorescent cannabinoid type 2 receptor ligands based on a 1,8-naphthyridin-2-(1H)-one-3-carboxamide scaffold. Medchemcomm.
Chicago Style CitationCooper, Anna G., Caitlin R. M. Oyagawa, Jamie J. Manning, Sameek Singh, Sarah Hook, Natasha L. Grimsey, Michelle Glass, Joel D. A. Tyndall, i Andrea J. Vernall. "Development of Selective, Fluorescent Cannabinoid Type 2 Receptor Ligands Based On a 1,8-naphthyridin-2-(1H)-one-3-carboxamide Scaffold." Medchemcomm 2018.
Cita MLACooper, Anna G., et al. "Development of Selective, Fluorescent Cannabinoid Type 2 Receptor Ligands Based On a 1,8-naphthyridin-2-(1H)-one-3-carboxamide Scaffold." Medchemcomm 2018.